|
US4444879A
(en)
|
1981-01-29 |
1984-04-24 |
Science Research Center, Inc. |
Immunoassay with article having support film and immunological counterpart of analyte
|
|
US4517289A
(en)
|
1982-08-18 |
1985-05-14 |
Brigham And Women's Hospital |
Monoclonal antibodies for human tissue cross-matching
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4921789A
(en)
|
1988-04-20 |
1990-05-01 |
New England Deaconess Hospital Corporation |
Marker for colorectal carcinoma and methods of detecting the same
|
|
US5344760A
(en)
|
1991-06-03 |
1994-09-06 |
Ciba Corning Diagnostics Corp. |
Method of cancer detection
|
|
US5786158A
(en)
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5790761A
(en)
|
1992-12-11 |
1998-08-04 |
Heseltine; Gary L. |
Method and apparatus for the diagnosis of colorectal cancer
|
|
AU6350894A
(en)
|
1993-03-05 |
1994-09-26 |
Clifford W. Schweinfest |
Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas
|
|
US7229770B1
(en)
|
1998-10-01 |
2007-06-12 |
The Regents Of The University Of California |
YKL-40 as a marker and prognostic indicator for cancers
|
|
DK85193D0
(da)
|
1993-07-16 |
1993-07-16 |
Cancerforskningsfondet Af 1989 |
Suppression of inhibitors
|
|
US6316208B1
(en)
|
1994-01-07 |
2001-11-13 |
Memorial Sloan-Kettering Cancer Center |
Methods for determining isolated p27 protein levels and uses thereof
|
|
CA2228970A1
(en)
|
1995-08-18 |
1997-02-27 |
Donald W. Landry |
Detection of organic compounds through regulation of antibody-catalyzed reactions
|
|
US5800347A
(en)
|
1995-11-03 |
1998-09-01 |
The General Hospital Corporation |
ROC method for early detection of disease
|
|
NO954667D0
(no)
|
1995-11-17 |
1995-11-17 |
Dagfinn Oegreid |
Fremgangsmåte til deteksjon av Ki-ras mutasjoner
|
|
US5983211A
(en)
|
1996-01-24 |
1999-11-09 |
Heseltine; Gary L. |
Method and apparatus for the diagnosis of colorectal cancer
|
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
GB9810040D0
(en)
|
1998-05-11 |
1998-07-08 |
Univ Nottingham |
Blood borne tumour markers
|
|
US6303372B1
(en)
|
1998-06-12 |
2001-10-16 |
Chiron Corporation |
cDNA molecule encoding human CIF130
|
|
GB9827228D0
(en)
|
1998-12-10 |
1999-02-03 |
Univ Nottingham |
Cancer detection method and reagents
|
|
WO2000070096A2
(en)
|
1999-01-10 |
2000-11-23 |
Exact Laboratories, Inc. |
Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
|
|
US7153700B1
(en)
|
1999-03-26 |
2006-12-26 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for diagnosing and predicting the behavior of cancer
|
|
AU771309B2
(en)
|
1999-04-09 |
2004-03-18 |
Rigshospitalet |
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
|
|
US20010041365A1
(en)
|
2000-01-10 |
2001-11-15 |
Michael Laposata |
Methods for monitoring alcohol consumption
|
|
US6322986B1
(en)
|
2000-01-18 |
2001-11-27 |
Albany Medical College |
Method for colorectal cancer prognosis and treatment selection
|
|
US7301016B2
(en)
|
2000-03-07 |
2007-11-27 |
Millennium Pharmaceuticals, Inc. |
Human transferase family members and uses thereof
|
|
US7577683B2
(en)
|
2000-06-08 |
2009-08-18 |
Ingenuity Systems, Inc. |
Methods for the construction and maintenance of a knowledge representation system
|
|
US6531283B1
(en)
|
2000-06-20 |
2003-03-11 |
Molecular Staging, Inc. |
Protein expression profiling
|
|
DE60142356D1
(de)
|
2000-07-18 |
2010-07-22 |
Millennium Pharm Inc |
18480 humane proteinkinasemoleküle und ihre verwendungen
|
|
US6706506B2
(en)
|
2000-07-24 |
2004-03-16 |
Cornell Research Foundation, Inc. |
Detection of epithelial cell cancers and precancerous conditions
|
|
WO2002077233A2
(en)
|
2000-11-08 |
2002-10-03 |
Millennium Pharmaceuticals, Inc. |
38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
|
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
|
US8043807B2
(en)
|
2001-03-23 |
2011-10-25 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
|
JP2005512510A
(ja)
|
2001-05-16 |
2005-05-12 |
ノバルティス アクチエンゲゼルシャフト |
予後および治療標的として乳癌で発現される遺伝子
|
|
US7031846B2
(en)
|
2001-08-16 |
2006-04-18 |
Affymetrix, Inc. |
Method, system, and computer software for the presentation and storage of analysis results
|
|
US8029764B2
(en)
|
2001-09-07 |
2011-10-04 |
The Johns Hopkins University |
Methods for detection of colorectal cancer
|
|
US20040018973A1
(en)
|
2002-01-25 |
2004-01-29 |
University Of Pittsburgh |
Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
|
|
US20030186248A1
(en)
|
2002-03-29 |
2003-10-02 |
Erlander Mark G. |
Interpreting cytological specimens via molecular histological signatures
|
|
EP1367395A1
(de)
|
2002-05-02 |
2003-12-03 |
B.R.A.H.M.S Aktiengesellschaft |
Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
|
|
WO2003097872A2
(en)
|
2002-05-21 |
2003-11-27 |
Mtm Laboratories Ag |
G - protein coupled receptor marker molecules associated with colorectal lesions
|
|
US20050153382A1
(en)
|
2002-06-06 |
2005-07-14 |
Chengdu Kuachang Science And Technology Co., Ltd. |
Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
|
|
US7425700B2
(en)
|
2003-05-22 |
2008-09-16 |
Stults John T |
Systems and methods for discovery and analysis of markers
|
|
US7526387B2
(en)
|
2003-07-10 |
2009-04-28 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
|
DE102004037860A1
(de)
|
2004-08-04 |
2006-03-16 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
|
|
PT1761779E
(pt)
|
2004-08-13 |
2008-02-01 |
Indivumed Gmbh |
Utilização de transtirretina como um biomarcador de adenoma colorrectal; método de detecção e sistema de teste
|
|
US20060105419A1
(en)
|
2004-08-16 |
2006-05-18 |
Biosite, Inc. |
Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
|
|
WO2006047483A2
(en)
|
2004-10-22 |
2006-05-04 |
Redpath Integrated Pathology, Inc. |
Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens
|
|
WO2006047787A2
(en)
|
2004-10-27 |
2006-05-04 |
Exact Sciences Corporation |
Method for monitoring disease progression or recurrence
|
|
WO2006094149A2
(en)
|
2005-03-01 |
2006-09-08 |
Exact Sciences Corporation |
Methods and compositions for detecting adenoma
|
|
US9075062B2
(en)
|
2005-03-22 |
2015-07-07 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Identification of biomarkers by serum protein profiling
|
|
US20090150315A1
(en)
|
2005-07-29 |
2009-06-11 |
Siemens Healthcare Diagnostics Inc. |
Neoplastic Disease-Related Methods, Kits, Systems and Databases
|
|
KR20080049821A
(ko)
|
2005-09-12 |
2008-06-04 |
페노미넘 디스커버리스 인코포레이티드 |
비타민 ｅ-관련 대사산물의 측정에 의한 결장암 및난소암의 진단방법
|
|
US20080255764A1
(en)
|
2005-09-12 |
2008-10-16 |
Phenomenome Discoveries Inc. |
Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
|
|
US7892758B2
(en)
|
2005-09-27 |
2011-02-22 |
University Of Saskatchewan |
Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis
|
|
WO2007141595A2
(en)
|
2005-11-10 |
2007-12-13 |
Aurelium Biopharma Inc. |
Method of diagnosing breast cancer using protein markers
|
|
GB0524190D0
(en)
|
2005-11-28 |
2006-01-04 |
Helse Stavanger Hf |
Method
|
|
ES2277785B1
(es)
|
2005-12-21 |
2008-06-16 |
Oryzon Genomics, S.A. |
Metodo de analisis de expresion diferencial en cancer colorectal.
|
|
US20090035801A1
(en)
|
2005-12-27 |
2009-02-05 |
Power3 Medical Products, Inc. |
Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer
|
|
NZ593226A
(en)
|
2006-01-11 |
2012-10-26 |
Genomic Health Inc |
Gene expression markers (efnb2) for colorectal cancer prognosis
|
|
WO2007090125A2
(en)
|
2006-01-30 |
2007-08-09 |
Introgen Therapeutics, Inc. |
Prognostic factors for anti-hyperproliferative disease gene therapy
|
|
WO2007127002A2
(en)
|
2006-03-31 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors
|
|
US7736624B2
(en)
|
2006-06-19 |
2010-06-15 |
Univ Vanderbilt |
Methods and compositions for diagnostic and therapeutic targeting of COX-2
|
|
US7811778B2
(en)
|
2006-09-06 |
2010-10-12 |
Vanderbilt University |
Methods of screening for gastrointestinal cancer
|
|
ES2543015T3
(es)
|
2006-12-08 |
2015-08-13 |
The Johns Hopkins University |
Estrategia de quimioprevención del cáncer basada en la pérdida de la impronta de IGF2
|
|
EP2111550B1
(en)
|
2007-01-26 |
2011-11-30 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
|
WO2008116178A2
(en)
|
2007-03-21 |
2008-09-25 |
Vanderbilt University |
Systems and methods for diagnosis and prognosis of colorectal cancer
|
|
AU2008300338A1
(en)
|
2007-06-04 |
2009-03-26 |
Diagnoplex |
Biomarker combinations for colorectal cancer
|
|
WO2009015299A1
(en)
|
2007-07-26 |
2009-01-29 |
California Pacific Medical Center |
Method to predict or diagnose a gastrointestinal disorder or disease
|
|
DE102007034993A1
(de)
|
2007-07-26 |
2009-01-29 |
Hanna Diehl |
Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor oder Darmkrebs
|
|
EP2195658A2
(en)
|
2007-09-28 |
2010-06-16 |
Royal College of Surgeons in Ireland |
A method of assessing colorectal cancer status in an individual
|
|
JP5227418B2
(ja)
|
2007-11-20 |
2013-07-03 |
エフ．ホフマン−ラ ロシュ アーゲー |
マーカー組み合わせカルプロテクチンおよびヘモグロビン／ハプトグロビン複合体の使用による便試料からの結腸直腸癌の評価方法
|
|
KR101058753B1
(ko)
|
2007-11-22 |
2011-08-24 |
한국생명공학연구원 |
대장암 마커로서의 ｅｓｍ－１ 유전자 및 이를 이용한대장암의 진단 및 치료에의 용도
|
|
MX2010004671A
(es)
|
2007-12-10 |
2010-05-27 |
Hoffmann La Roche |
Seprasa como marcador para cancer.
|
|
ES2527649T3
(es)
*
|
2007-12-10 |
2015-01-28 |
F. Hoffmann-La Roche Ag |
Panel de marcadores para el cáncer colorrectal
|
|
WO2009099649A1
(en)
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin and bevacizumab to treat colorectal cancer
|
|
WO2009101620A1
(en)
|
2008-02-11 |
2009-08-20 |
Hadasit Medical Research Services & Development Limited |
Colon cancer associated transcript 1 (ccat1) as a cancer marker
|
|
WO2009107170A1
(ja)
|
2008-02-29 |
2009-09-03 |
学校法人日本大学 |
抗ｃｒｐ抗体及びその利用
|
|
WO2009115920A1
(en)
|
2008-03-18 |
2009-09-24 |
Epigenomics Ag |
A method for optimizing and validating an assay for determining the presence or absence of a medical condition
|
|
CA2718918A1
(en)
|
2008-03-25 |
2009-11-26 |
Schering Corporation |
Methods for treating or preventing colorectal cancer
|
|
US8921074B2
(en)
|
2008-04-10 |
2014-12-30 |
Genenews, Inc. |
Method and apparatus for determining a probability of colorectal cancer in a subject
|
|
CA2724433A1
(en)
|
2008-05-14 |
2009-11-19 |
Eth Zuerich |
Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
|
|
EP2796878A1
(en)
|
2008-05-23 |
2014-10-29 |
Biocartis NV |
New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof
|
|
WO2010009368A2
(en)
|
2008-07-18 |
2010-01-21 |
Oragenics, Inc. |
Compositions for the detection and treatment of colorectal cancer
|
|
EP2169077A1
(en)
|
2008-09-19 |
2010-03-31 |
Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg |
Methods and compositions for diagnosing an adenocarcinoma
|
|
US20100204299A1
(en)
|
2009-02-11 |
2010-08-12 |
Daniel Regnier |
C-cbl and antagonists thereof for the treatment and diagnosis of cancer
|
|
WO2010096154A2
(en)
*
|
2009-02-20 |
2010-08-26 |
Onconome, Inc. |
Compositions and methods for diagnosis and prognosis of colorectal cancer
|
|
CN102326081B
(zh)
|
2009-02-24 |
2014-11-19 |
霍夫曼-拉罗奇有限公司 |
s-ErbB-3作为癌症标志物的应用
|
|
CA2777800C
(en)
|
2009-10-15 |
2019-11-12 |
Crescendo Bioscience |
Biomarkers and methods for measuring and monitoring inflammatory disease activity
|
|
US7736861B1
(en)
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
|
EP2501845A4
(en)
*
|
2009-11-20 |
2013-04-24 |
Univ Louisville Res Found |
KREBSBIOMARKER
|
|
US20110236916A1
(en)
|
2010-03-26 |
2011-09-29 |
Mayo Foundation For Medical Education And Research |
Methods and materials for detecting colorectal neoplasm
|
|
US10119959B2
(en)
|
2010-06-25 |
2018-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of assaying an individual for immune impairment
|
|
GB201012590D0
(en)
|
2010-07-27 |
2010-09-08 |
Queen Mary & Westfield College |
Methods for diagnosing cancer
|
|
US8389684B2
(en)
|
2010-09-13 |
2013-03-05 |
Tsinghua University |
Tumor biomarker
|
|
EP2668503B1
(en)
|
2011-01-28 |
2015-06-24 |
F.Hoffmann-La Roche Ag |
Combinatorial biomarkers for clinical applications in lung cancer patient management
|
|
WO2012115885A1
(en)
|
2011-02-22 |
2012-08-30 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Circulating biomarkers
|
|
EP2744919A4
(en)
|
2011-08-19 |
2015-04-08 |
Myriad Genetics Inc |
GENE SIGNATURES FOR PROGNOSIS OF LUNG CANCER AND SELECTION OF THERAPY
|
|
WO2013152989A2
(en)
|
2012-04-10 |
2013-10-17 |
Eth Zurich |
Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
|
|
EP3671215B1
(en)
*
|
2012-04-26 |
2023-03-29 |
Stichting VUmc |
Biomarkers
|
|
WO2014085826A2
(en)
|
2012-11-30 |
2014-06-05 |
Applied Proteomics, Inc. |
Method for evaluation of presence of or risk of colon tumors
|